JP Morgan increased its stake in Pharmaron Beijing (03759) by approximately 2.26 million shares at a price of around HK$16.43 per share.
On February 17th, Morgan Stanley increased its holdings in Kanglong Chemical (03759) by 2,262,327 shares, at a price of HK$16.4321 per share, totaling approximately HK$37.1748 million.
According to the latest data from the Hong Kong Stock Exchange, on February 17, JP Morgan increased its holdings of Pharmaron Beijing (03759) by 2,262,327 shares, at a price of 16.4321 Hong Kong dollars per share, totaling approximately 37.1748 million Hong Kong dollars. After the increase, the new total number of shares held is approximately 14.9761 million, with a new holding percentage of 5.08%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
